ANI Pharmaceuticals SG&A Expense (Quarterly) Insights

ANI Pharmaceuticals Inc (ANIP)

65.50 -0.53 (-0.80%) USD | NASDAQ | May 15, 14:10

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1999. Upgrade now.

Date	Value
March 31, 2024	48.02M
December 31, 2023	44.46M
September 30, 2023	42.01M
June 30, 2023	38.76M
March 31, 2023	36.47M
December 31, 2022	33.19M
September 30, 2022	30.08M
June 30, 2022	31.96M
March 31, 2022	28.82M
December 31, 2021	30.71M
September 30, 2021	17.18M
June 30, 2021	18.82M
March 31, 2021	17.59M
December 31, 2020	14.36M
September 30, 2020	15.72M
June 30, 2020	21.21M
March 31, 2020	13.68M
December 31, 2019	14.01M
September 30, 2019	14.36M
June 30, 2019	14.19M
March 31, 2019	13.28M
December 31, 2018	13.38M
September 30, 2018	11.77M
June 30, 2018	9.962M
March 31, 2018	8.956M

Date	Value
December 31, 2017	8.885M
September 30, 2017	8.022M
June 30, 2017	7.38M
March 31, 2017	7.293M
December 31, 2016	7.369M
September 30, 2016	6.928M
June 30, 2016	7.628M
March 31, 2016	5.904M
December 31, 2015	5.455M
September 30, 2015	5.399M
June 30, 2015	5.551M
March 31, 2015	4.751M
December 31, 2014	4.742M
September 30, 2014	4.057M
June 30, 2014	5.433M
March 31, 2014	3.703M
December 31, 2013	3.427M
September 30, 2013	3.48M
June 30, 2013	7.172M
March 31, 2013	1.949M
December 31, 2012	2.902M
September 30, 2012	1.547M
June 30, 2012	1.949M
March 31, 2012	1.832M
December 31, 2011	1.724M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

13.68M

Minimum

Mar 2020

48.02M

Maximum

Mar 2024

26.28M

Average

25.02M

Median

SG&A Expense (Quarterly) Benchmarks